Actively Recruiting
Dual-port Trans-subclavian Thyroid Endoscopic Surgery - an Exploration of Cavity Construction in Situ Heralds a New Approach Choice
Led by First Affiliated Hospital of Wenzhou Medical University · Updated on 2024-12-31
300
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are exploring a new surgical method called Dual-port Trans-subclavian Thyroid Endoscopic Surgery (DTS) for patients with thyroid tumors. This open-label, non-randomized study compares DTS with the traditional open thyroidectomy (COT) to assess safety and effectiveness. The trial aims to build evidence on how this new approach may improve surgery outcomes and reduce complications for thyroid cancer and benign tumors. The study involves two groups: one undergoing the innovative DTS technique using two small puncture holes to minimize trauma and improve cosmetic results, and the other receiving the standard open thyroid surgery with collar incisions. DTS creates a surgical cavity directly in the neck, potentially reducing tissue damage, pain, and hospital stay compared to the conventional method. Both groups receive surgery as per their treatment choice, and detailed medical data are collected throughout. Participants will be monitored before and after surgery through laboratory tests measuring immune and hormonal markers, pain assessments, and tracking of surgical outcomes like hospital stay length and wound satisfaction over three months. Safety is carefully observed through recording adverse events, vital signs, and pathology exams. The primary measure is the rate of postoperative complications, with follow-up extending up to 100 months to evaluate long-term results.
CONDITIONS
Brief Title
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 90 years
- Diagnosed with thyroid cancer or benign thyroid tumors
- Patients seeking improved cosmetic results from surgery
You will not qualify if you...
- Thyroid cancer larger than 2 cm
- Benign tumors larger than 5 cm
- Presence of severe underlying diseases
- Chronic kidney disease
- Autoimmune diseases
- Rheumatoid arthritis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to discharge from hospital
Participants undergo either Dual-port Trans-subclavian Thyroid Endoscopic Surgery (DTS) or conventional open thyroidectomy (COT), followed by immediate post-operative care to monitor recovery and manage any complications.
1 surgical procedure and approximately 1 hospital stay
Duration - Up to 100 months
Participants receive follow-up visits to assess recovery, monitor for postoperative complications, and evaluate surgical outcomes.
Scheduled visits as determined by the clinical team over the follow-up period
Trial Site Locations
Total: 1 location
1
First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, China, 325000
Actively Recruiting
Research Team
C
Chun Jin, Professor
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here